Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bifidobacterium longum subsp. infantis ABC transporter substrate-binding proteins (SBPs) are specialized proteins located in the periplasm or anchored to the cell membrane of the probiotic bacterium B. infantis. These proteins play a critical role in the selective uptake of human milk oligosaccharides (HMOs), which are complex carbohydrates found in breast milk that are indigestible by the human host (Sela et al., 2008, PNAS). By binding specifically to various HMO structures—such as 2'-fucosyllactose and lacto-N-tetraose—these SBPs facilitate the transport of these nutrients into the bacterial cell for fermentation (Garrido et al., 2011, PLoS ONE). This process provides B. infantis with a competitive advantage in the infant gut, promoting a healthy microbiome dominated by beneficial bacteria and lowering gut pH through the production of organic acids. Therapeutically, these proteins are targeted through the administration of specific prebiotics (HMOs) or synbiotics to prevent dysbiosis, necrotizing enterocolitis, and other inflammatory conditions in neonates (Underwood et al., 2013, Pediatric Research). The high affinity and specificity of these SBPs, such as Blon_2177, ensure that B. infantis can efficiently capture even low concentrations of complex glycans in the competitive gut environment (UniProt, B7GPL1).
Substrate sequestration and delivery to the transmembrane permease of the ABC transporter system for intracellular translocation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bifidobacterium longum subsp. infantis ABC transporter substrate-binding protein for human milk oligosaccharides (B. infantis HMO SBP).